After suffering from a rare condition and a skin infection, Sprinkles is finally on the road to recovery Waking up to a trail of drool on the cheek is unpleasant for anyone, but for one koala in ...

The sBLA approval was based on data from a phase 3 study evaluating Xeomin in 216 patients aged 6 to 17 years with chronic sialorrhea associated with cerebral palsy, other genetic or congenital ...

A wild koala in Australia has received its first dose of radiation therapy to treat a rare case of excessive drooling, The Courier-Mail reported Wednesday. Australia Zoo Wildlife Hospital veterinarian ...

Sialorrhea is a common and often debilitating, socially isolating and embarrassing symptom for patients with Parkinson disease (PD). The treatment of sialorrhea involves the management of saliva ...

A new study has revealed the most effective medications to reduce drooling in young people with a developmental disability, which can affect their socialisation, relationships and community life. The ...

The approval was supported by data from a Phase 3, randomized, double-blind, placebo-controlled, multicenter (N=184) trial. Merz North America announced that the Food and Drug Administration (FDA) has ...

Dublin, Jan. 27, 2020 (GLOBE NEWSWIRE) -- The "Sialorrhea - Market Insights, Epidemiology and Market Forecast - 2028" drug pipelines has been added to ResearchAndMarkets.com's offering. This report ...

New chemical entity and selective muscarinic receptor antagonist targeting large unmet need for a new treatment that can meaningfully improve the lives of patients with neurological conditions DALLAS ...

Neos Therapeutics, Inc., a fully-integrated pharmaceutical company, announced that it has licensed NRX 101, a candidate for the treatment of sialorrhea (excessive salivation or drooling) from NeuRx ...

Naomi Cocks has received funding from Parkinson’s WA. Imagine not wanting to leave your house because of fear you would drool. That’s the choice many people with Parkinson’s disease confront every day ...